SCR-LIP-000576 · Claim · machine-readable JSON →

This conceptual review proposes that lipedema represents a regionally patterned adipose dysregulation that may coexist with relatively preserved systemic metabolic function, in contrast to obesity-related adipose dysfunction linked to insulin resistance and cardiometabolic risk.

This single-paper claim was consolidated into general propositions (R-CLM-19); its evidence now sits under:

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
low (GRADE)
Evidence
1 source(s)
Dates
2026-11-17 → 2026-11-17

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17

Evidence over time

2026The Adipovascular Unit in Lipedema: A Framework for Regional Adipose Tissue Dysregulation. — Faulhaber J, Hanke CW, Barsch M, Sandhofer M. (2026) · refining

Evidence (1)

Context (PECO)

Populationindividuals with lipedema (predominantly female)
Conditionlipedema
Exposureregional/peripheral subcutaneous adipose tissue expansion (lipedema)
Comparatorobesity-associated adipose dysfunction
Outcomesystemic metabolic function / cardiometabolic risk
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log